(2R)-N-[(2R)-1-[[(2S)-1-[[(Z)-1-[[(3R,6R,9S,12S,15S,16R)-3-(4-aminobutyl)-6-(2-aminoethyl)-12-[(2S)-butan-2-yl]-9-(2-hydroxyethyl)-16-methyl-2,5,8,11,14-pentaoxo-1-oxa-4,7,10,13-tetrazacyclohexadec-15-yl]amino]-1-oxobut-2-en-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]-2-[[(2R)-2-[[(2S)-2-[[(2R)-2-[[(2S)-3-hydroxy-2-[[(2R)-2-[[(2S)-2-[[(2R)-3-hydroxy-2-[[(2S)-1-[(Z)-2-[[(3S)-3-hydroxyheptanoyl]amino]but-2-enoyl]pyrrolidine-2-carbonyl]amino]propanoyl]amino]-4-methylpentanoyl]amino]-3-methylbutanoyl]amino]propanoyl]amino]-4-methylpentanoyl]amino]-3-methylbutanoyl]amino]-3-methylbutanoyl]amino]pentanediamide
| Internal ID | 447b8305-4e66-490f-b07c-dd761eef0631 |
| Taxonomy | Organic acids and derivatives > Peptidomimetics > Depsipeptides > Cyclic depsipeptides |
| IUPAC Name | (2R)-N-[(2R)-1-[[(2S)-1-[[(Z)-1-[[(3R,6R,9S,12S,15S,16R)-3-(4-aminobutyl)-6-(2-aminoethyl)-12-[(2S)-butan-2-yl]-9-(2-hydroxyethyl)-16-methyl-2,5,8,11,14-pentaoxo-1-oxa-4,7,10,13-tetrazacyclohexadec-15-yl]amino]-1-oxobut-2-en-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]-2-[[(2R)-2-[[(2S)-2-[[(2R)-2-[[(2S)-3-hydroxy-2-[[(2R)-2-[[(2S)-2-[[(2R)-3-hydroxy-2-[[(2S)-1-[(Z)-2-[[(3S)-3-hydroxyheptanoyl]amino]but-2-enoyl]pyrrolidine-2-carbonyl]amino]propanoyl]amino]-4-methylpentanoyl]amino]-3-methylbutanoyl]amino]propanoyl]amino]-4-methylpentanoyl]amino]-3-methylbutanoyl]amino]-3-methylbutanoyl]amino]pentanediamide |
| SMILES (Canonical) | CCCCC(CC(=O)NC(=CC)C(=O)N1CCCC1C(=O)NC(CO)C(=O)NC(CC(C)C)C(=O)NC(C(C)C)C(=O)NC(CO)C(=O)NC(CC(C)C)C(=O)NC(C(C)C)C(=O)NC(C(C)C)C(=O)NC(CCC(=O)N)C(=O)NC(CC(C)C)C(=O)NC(C(C)C)C(=O)NC(=CC)C(=O)NC2C(OC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC2=O)C(C)CC)CCO)CCN)CCCCN)C)O |
| SMILES (Isomeric) | CCCC[C@@H](CC(=O)N/C(=C\C)/C(=O)N1CCC[C@H]1C(=O)N[C@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@H](C(C)C)C(=O)N[C@H](CCC(=O)N)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N/C(=C\C)/C(=O)N[C@H]2[C@H](OC(=O)[C@H](NC(=O)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC2=O)[C@@H](C)CC)CCO)CCN)CCCCN)C)O |
| InChI | InChI=1S/C93H161N21O25/c1-21-25-29-55(118)43-69(120)97-57(24-4)92(137)114-38-28-31-67(114)85(130)106-65(44-116)83(128)104-63(41-47(7)8)81(126)109-71(50(13)14)88(133)107-66(45-117)84(129)105-64(42-48(9)10)82(127)110-73(52(17)18)89(134)111-72(51(15)16)87(132)100-58(32-33-68(96)119)77(122)103-62(40-46(5)6)80(125)108-70(49(11)12)86(131)98-56(23-3)76(121)113-75-54(20)139-93(138)61(30-26-27-36-94)102-78(123)59(34-37-95)99-79(124)60(35-39-115)101-90(135)74(53(19)22-2)112-91(75)136/h23-24,46-55,58-67,70-75,115-118H,21-22,25-45,94-95H2,1-20H3,(H2,96,119)(H,97,120)(H,98,131)(H,99,124)(H,100,132)(H,101,135)(H,102,123)(H,103,122)(H,104,128)(H,105,129)(H,106,130)(H,107,133)(H,108,125)(H,109,126)(H,110,127)(H,111,134)(H,112,136)(H,113,121)/b56-23-,57-24-/t53-,54+,55-,58+,59+,60-,61+,62+,63-,64+,65+,66-,67-,70-,71+,72+,73-,74-,75-/m0/s1 |
| InChI Key | CUZXLJGPMDNJSI-SNJLTZIISA-N |
| Popularity | 0 references in papers |
| Molecular Formula | C93H161N21O25 |
| Molecular Weight | 1973.40 g/mol |
| Exact Mass | 1972.19724971 g/mol |
| Topological Polar Surface Area (TPSA) | 717.00 Ų |
| XlogP | 1.70 |
| Atomic LogP (AlogP) | -3.91 |
| H-Bond Acceptor | 27 |
| H-Bond Donor | 24 |
| Rotatable Bonds | 56 |
| There are no found synonyms. |
| Target | Value | Probability (raw) | Probability (%) |
|---|---|---|---|
| Human Intestinal Absorption | + | 0.7098 | 70.98% |
| Caco-2 | - | 0.8585 | 85.85% |
| Blood Brain Barrier | - | 0.9000 | 90.00% |
| Human oral bioavailability | - | 0.6000 | 60.00% |
| Subcellular localzation | Lysosomes | 0.5340 | 53.40% |
| OATP2B1 inhibitior | - | 1.0000 | 100.00% |
| OATP1B1 inhibitior | + | 0.8121 | 81.21% |
| OATP1B3 inhibitior | + | 0.9159 | 91.59% |
| MATE1 inhibitior | - | 0.9412 | 94.12% |
| OCT2 inhibitior | - | 0.9500 | 95.00% |
| BSEP inhibitior | + | 0.9790 | 97.90% |
| P-glycoprotein inhibitior | + | 0.7418 | 74.18% |
| P-glycoprotein substrate | + | 0.8776 | 87.76% |
| CYP3A4 substrate | + | 0.7489 | 74.89% |
| CYP2C9 substrate | - | 1.0000 | 100.00% |
| CYP2D6 substrate | - | 0.8458 | 84.58% |
| CYP3A4 inhibition | - | 0.8681 | 86.81% |
| CYP2C9 inhibition | - | 0.8955 | 89.55% |
| CYP2C19 inhibition | - | 0.8789 | 87.89% |
| CYP2D6 inhibition | - | 0.9217 | 92.17% |
| CYP1A2 inhibition | - | 0.9022 | 90.22% |
| CYP2C8 inhibition | + | 0.7857 | 78.57% |
| CYP inhibitory promiscuity | - | 0.9770 | 97.70% |
| UGT catelyzed | + | 0.7000 | 70.00% |
| Carcinogenicity (binary) | - | 0.8600 | 86.00% |
| Carcinogenicity (trinary) | Non-required | 0.5372 | 53.72% |
| Eye corrosion | - | 0.9835 | 98.35% |
| Eye irritation | - | 0.8954 | 89.54% |
| Skin irritation | - | 0.7559 | 75.59% |
| Skin corrosion | - | 0.9073 | 90.73% |
| Ames mutagenesis | - | 0.6400 | 64.00% |
| Human Ether-a-go-go-Related Gene inhibition | + | 0.7060 | 70.60% |
| Micronuclear | + | 0.8400 | 84.00% |
| Hepatotoxicity | - | 0.5239 | 52.39% |
| skin sensitisation | - | 0.8526 | 85.26% |
| Respiratory toxicity | + | 0.7556 | 75.56% |
| Reproductive toxicity | + | 0.8333 | 83.33% |
| Mitochondrial toxicity | + | 0.8125 | 81.25% |
| Nephrotoxicity | + | 0.8365 | 83.65% |
| Acute Oral Toxicity (c) | III | 0.5838 | 58.38% |
| Estrogen receptor binding | - | 0.4759 | 47.59% |
| Androgen receptor binding | + | 0.7429 | 74.29% |
| Thyroid receptor binding | + | 0.7234 | 72.34% |
| Glucocorticoid receptor binding | + | 0.8057 | 80.57% |
| Aromatase binding | + | 0.8052 | 80.52% |
| PPAR gamma | + | 0.7808 | 78.08% |
| Honey bee toxicity | - | 0.6768 | 67.68% |
| Biodegradation | - | 0.7500 | 75.00% |
| Crustacea aquatic toxicity | - | 0.5500 | 55.00% |
| Fish aquatic toxicity | + | 0.8160 | 81.60% |
Proven Targets:
| CHEMBL ID | UniProt ID | Name | Min activity | Assay type | Source |
|---|---|---|---|---|---|
| No proven targets yet! | |||||
Predicted Targets (via Super-PRED):
| CHEMBL ID | UniProt ID | Name | Probability | Model accuracy |
|---|---|---|---|---|
| CHEMBL3837 | P07711 | Cathepsin L | 99.98% | 96.61% |
| CHEMBL2581 | P07339 | Cathepsin D | 99.78% | 98.95% |
| CHEMBL4801 | P29466 | Caspase-1 | 99.10% | 96.85% |
| CHEMBL2730 | P21980 | Protein-glutamine gamma-glutamyltransferase | 98.91% | 92.38% |
| CHEMBL1795139 | Q8IU80 | Transmembrane protease serine 6 | 98.89% | 98.33% |
| CHEMBL237 | P41145 | Kappa opioid receptor | 98.50% | 98.10% |
| CHEMBL4588 | P22894 | Matrix metalloproteinase 8 | 98.20% | 94.66% |
| CHEMBL3137262 | O60341 | LSD1/CoREST complex | 98.12% | 97.09% |
| CHEMBL3359 | P21462 | Formyl peptide receptor 1 | 98.11% | 93.56% |
| CHEMBL2208 | P49137 | MAP kinase-activated protein kinase 2 | 97.63% | 95.20% |
| CHEMBL2693 | Q9UIQ6 | Cystinyl aminopeptidase | 97.51% | 97.64% |
| CHEMBL230 | P35354 | Cyclooxygenase-2 | 97.45% | 89.63% |
| CHEMBL3130 | O00329 | PI3-kinase p110-delta subunit | 97.44% | 96.47% |
| CHEMBL253 | P34972 | Cannabinoid CB2 receptor | 97.30% | 97.25% |
| CHEMBL3251 | P19838 | Nuclear factor NF-kappa-B p105 subunit | 97.25% | 96.09% |
| CHEMBL2094135 | Q96BI3 | Gamma-secretase | 97.16% | 98.05% |
| CHEMBL2514 | O95665 | Neurotensin receptor 2 | 97.14% | 100.00% |
| CHEMBL4296 | Q15858 | Sodium channel protein type IX alpha subunit | 96.49% | 96.11% |
| CHEMBL1801 | P00747 | Plasminogen | 96.20% | 92.44% |
| CHEMBL2492 | P36544 | Neuronal acetylcholine receptor protein alpha-7 subunit | 95.88% | 88.42% |
| CHEMBL5043 | Q6P179 | Endoplasmic reticulum aminopeptidase 2 | 95.82% | 91.81% |
| CHEMBL5619 | P27695 | DNA-(apurinic or apyrimidinic site) lyase | 95.71% | 91.11% |
| CHEMBL3060 | Q9Y345 | Glycine transporter 2 | 95.57% | 99.17% |
| CHEMBL3468 | P55210 | Caspase-7 | 95.35% | 95.68% |
| CHEMBL5103 | Q969S8 | Histone deacetylase 10 | 95.30% | 90.08% |
| CHEMBL4018 | P49146 | Neuropeptide Y receptor type 2 | 94.99% | 98.94% |
| CHEMBL4478 | Q00975 | Voltage-gated N-type calcium channel alpha-1B subunit | 94.96% | 97.14% |
| CHEMBL1944495 | P28065 | Proteasome subunit beta type-9 | 94.57% | 97.50% |
| CHEMBL4123 | P30989 | Neurotensin receptor 1 | 94.44% | 96.67% |
| CHEMBL2107 | P61073 | C-X-C chemokine receptor type 4 | 93.39% | 93.10% |
| CHEMBL4187 | Q99250 | Sodium channel protein type II alpha subunit | 93.18% | 95.50% |
| CHEMBL221 | P23219 | Cyclooxygenase-1 | 93.14% | 90.17% |
| CHEMBL4227 | P25090 | Lipoxin A4 receptor | 92.97% | 100.00% |
| CHEMBL4072 | P07858 | Cathepsin B | 92.91% | 93.67% |
| CHEMBL3392948 | Q9NP59 | Solute carrier family 40 member 1 | 92.71% | 95.00% |
| CHEMBL3145 | P42338 | PI3-kinase p110-beta subunit | 92.65% | 98.75% |
| CHEMBL340 | P08684 | Cytochrome P450 3A4 | 92.30% | 91.19% |
| CHEMBL2072 | P35499 | Sodium channel protein type IV alpha subunit | 92.21% | 92.32% |
| CHEMBL2069156 | Q14145 | Kelch-like ECH-associated protein 1 | 92.11% | 82.38% |
| CHEMBL3024 | P53350 | Serine/threonine-protein kinase PLK1 | 91.92% | 97.43% |
| CHEMBL259 | P32245 | Melanocortin receptor 4 | 91.76% | 95.38% |
| CHEMBL5845 | P23415 | Glycine receptor subunit alpha-1 | 91.53% | 90.71% |
| CHEMBL3267 | P48736 | PI3-kinase p110-gamma subunit | 91.50% | 95.71% |
| CHEMBL3108638 | O15164 | Transcription intermediary factor 1-alpha | 91.05% | 95.56% |
| CHEMBL4979 | P13866 | Sodium/glucose cotransporter 1 | 90.98% | 98.24% |
| CHEMBL3176 | O43603 | Galanin receptor 2 | 90.92% | 98.89% |
| CHEMBL5163 | Q9NY46 | Sodium channel protein type III alpha subunit | 90.92% | 96.90% |
| CHEMBL4026 | P40763 | Signal transducer and activator of transcription 3 | 90.73% | 82.69% |
| CHEMBL4581 | P52732 | Kinesin-like protein 1 | 90.58% | 93.18% |
| CHEMBL2955 | O95136 | Sphingosine 1-phosphate receptor Edg-5 | 90.05% | 92.86% |
| CHEMBL2274 | Q9H228 | Sphingosine 1-phosphate receptor Edg-8 | 89.74% | 100.00% |
| CHEMBL1907591 | P30926 | Neuronal acetylcholine receptor; alpha4/beta4 | 89.21% | 100.00% |
| CHEMBL3892 | Q99500 | Sphingosine 1-phosphate receptor Edg-3 | 89.13% | 97.29% |
| CHEMBL3310 | Q96DB2 | Histone deacetylase 11 | 88.40% | 88.56% |
| CHEMBL2111367 | P27986 | PI3-kinase p110-alpha/p85-alpha | 88.12% | 94.33% |
| CHEMBL1907605 | P24864 | Cyclin-dependent kinase 2/cyclin E1 | 88.10% | 92.88% |
| CHEMBL4203 | Q9HAZ1 | Dual specificity protein kinase CLK4 | 87.99% | 94.45% |
| CHEMBL3807 | P17706 | T-cell protein-tyrosine phosphatase | 87.78% | 93.00% |
| CHEMBL4005 | P42336 | PI3-kinase p110-alpha subunit | 86.94% | 97.47% |
| CHEMBL332 | P03956 | Matrix metalloproteinase-1 | 86.43% | 94.50% |
| CHEMBL4374 | Q9Y5X4 | Photoreceptor-specific nuclear receptor | 86.01% | 85.00% |
| CHEMBL1075317 | P61964 | WD repeat-containing protein 5 | 85.46% | 96.33% |
| CHEMBL321 | P14780 | Matrix metalloproteinase 9 | 84.45% | 92.12% |
| CHEMBL333 | P08253 | Matrix metalloproteinase-2 | 84.09% | 96.31% |
| CHEMBL2413 | P32246 | C-C chemokine receptor type 1 | 84.02% | 89.50% |
| CHEMBL2781 | P19634 | Sodium/hydrogen exchanger 1 | 83.97% | 90.24% |
| CHEMBL3476 | O15111 | Inhibitor of nuclear factor kappa B kinase alpha subunit | 83.66% | 95.83% |
| CHEMBL5852 | Q96P65 | Pyroglutamylated RFamide peptide receptor | 83.59% | 85.00% |
| CHEMBL3880 | P07900 | Heat shock protein HSP 90-alpha | 83.15% | 96.21% |
| CHEMBL1907600 | Q00535 | Cyclin-dependent kinase 5/CDK5 activator 1 | 83.14% | 93.03% |
| CHEMBL4625 | Q07817 | Apoptosis regulator Bcl-X | 82.86% | 99.77% |
| CHEMBL1075094 | Q16236 | Nuclear factor erythroid 2-related factor 2 | 82.48% | 96.00% |
| CHEMBL4777 | P25929 | Neuropeptide Y receptor type 1 | 82.42% | 96.67% |
| CHEMBL299 | P17252 | Protein kinase C alpha | 82.31% | 98.03% |
| CHEMBL1907594 | P30926 | Neuronal acetylcholine receptor; alpha3/beta4 | 82.03% | 97.23% |
| CHEMBL2001 | Q9H244 | Purinergic receptor P2Y12 | 81.53% | 96.00% |
| CHEMBL4481 | P35228 | Nitric oxide synthase, inducible | 81.51% | 94.80% |
| CHEMBL1907589 | P17787 | Neuronal acetylcholine receptor; alpha4/beta2 | 81.26% | 94.55% |
| CHEMBL1994 | P08235 | Mineralocorticoid receptor | 81.22% | 100.00% |
| CHEMBL5608 | Q16288 | NT-3 growth factor receptor | 81.13% | 95.89% |
Below are displayed all the plants proven (via scientific papers) to contain this
compound!
To see more specific details click the taxa you are interested in.
To see more specific details click the taxa you are interested in.
| There are no matching plants. |
| PubChem | 163103751 |
| LOTUS | LTS0136970 |
| wikiData | Q104970602 |